HIV and the liver [0.03%]
HIV与肝脏
Kenneth E Sherman,Marion G Peters,David L Thomas
Kenneth E Sherman
Among individuals with HIV infection, liver disease remains an important cause of morbidity and mortality, even with the availability of agents that cure hepatitis C infection and suppress hepatitis B replication. The causes of liver diseas...
The Ryan White HIV/AIDS Program after the Patient Protection and Affordable Care Act full implementation: a critical review of predictions, evidence, and future directions [0.03%]
《病人保护与平价医疗法案》全面实施后莱安怀特艾滋病项目前景的批判性回顾：预测、证据和未来方向
Tamar Ginossar,John Oetzel,Lindsay Van Meter et al.
Tamar Ginossar et al.
The Ryan White HIV/AIDS Program (RWHAP) has been effective in serving people living with HIV (PLWH). Our goal was to examine the impact of the implementation of the Affordable Care Act (ACA) on the program's role in HIV care and its clients...
Michael S Saag
Michael S Saag
Antiretroviral therapy (ART) should be started as soon as possible after HIV diagnosis. Recommended starting ART regimens in patients with any baseline viral load include ictegravir plus tenofovir alafenamide (TAF)/emtricitabine (FTC), dolu...
Barbara S Taylor,Hong-Van Tieu,Joyce Jones et al.
Barbara S Taylor et al.
The 2019 Conference on Retroviruses and Opportunistic Infections included many exciting advances in antiretroviral therapy (ART). Investigators presented a case report of a second patient possibly cured of HIV through an allogeneic hematopo...
Anne F Luetkemeyer,David L Wyles
Anne F Luetkemeyer
At the 2019 Conference on Retroviruses and Opportunistic Infections (CROI), there was a major focus on hepatitis C virus (HCV) elimination and improving each component of the hepatitis C care cascade. Many interventions showed promising imp...
CROI 2019: complications and coinfections in HIV infection [0.03%]
第26届逆转录病毒和机会性感染会议（CROI 2019）：艾滋病病毒感染的并发症与合并症
Judith S Currier,Diane V Havlir
Judith S Currier
The 2019 Conference on Retroviruses and Opportunistic Infections provided a considerable amount of new information on the progress in implementation of strategies to reduce morbidity and mortality from complications and coinfections that oc...
Beau M Ances,Scott L Letendre
Beau M Ances
Investigators reported many new neuroHIV research findings at the 2019 Conference on Retroviruses and Opportunistic Infections (CROI). These findings included confirmation that HIV-associated neurocognitive disorder (HAND) remains common wi...
CROI 2019: advances in HIV prevention and plans to end the epidemic [0.03%]
第26届逆转录病毒和机会性感染大会(CROI 2019)聚焦HIV预防进展及终结艾滋病疫情的计划
Susan P Buchbinder,Albert Y Liu
Susan P Buchbinder
At the 2019 Conference on Retroviruses and Opportunistic Infections (CROI), a plan for ending the HIV epidemic in the United States was presented. More rapid HIV diagnosis and treatment is a key component needed nationwide. In international...
CROI 2019: advances in basic science understanding of HIV [0.03%]
2019年逆转录病毒和机会性感染大会(CROI)：HIV基础科学研究进展
Mario Stevenson
Mario Stevenson
The annual Conference on Retroviruses and Opportunistic Infections remains the preeminent venue for the sharing and dissemination of research advances in the field of HIV and AIDS research. The 26th conference in Seattle featured highlights...
Aradhna Seth,Kenneth E Sherman
Aradhna Seth
The leading cause of non-HIV-related mortality is liver disease. Fatty liver disease can be characterized as alcoholic or nonalcoholic in nature. Alcohol use is prevalent among individuals with HIV infection and can lead to medication nonad...